Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 47,700 | reported | 18 Dec 2025 | tx 25+1,045,689−1,716,424 |
| Latch, Inc. | 30,000 | reported | 04 Jun 2021 | tx 2+30,000−30,000 |
| DENALI SCIENCES, INC. | 25,000 | reported | 01 May 2008 | tx 1+25,000 |
| Diamond Eagle Acquisition Corp. \ DE | 20,000 | reported | 31 Dec 2019 | tx 1+20,000 |
| CAPRICOR THERAPEUTICS, INC. | 18,000 | reported | 02 Jan 2018 | tx 34+1,174,208−25,246 |
| Target Hospitality Corp. | 10,000 | reported | 05 Mar 2019 | tx 4+363,334 |
| Tishman Speyer Innovation Corp. II | 5,000 | reported | 12 Feb 2021 | tx 2+30,000 |
| Kite Pharma, Inc. | 0 | reported | 03 Oct 2017 | tx 19+140,220−627,720 |
| Kronos Bio, Inc. | 0 | reported | 20 Jun 2025 | tx 15+425,971−515,637 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Dec 2025 | EXERCISE | Allogene Therapeutics, Inc. | 47,700 | 0.00 USD | |
| 18 Dec 2025 | EXERCISE | Allogene Therapeutics, Inc. | 47,700 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 94,500 | 0.00 USD | deriv |
| 20 Jun 2025 | TENDER | Kronos Bio, Inc. | 94,481 | 0.57 USD | |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 20,600 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 191,082 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Allogene Therapeutics, Inc. | 116,120 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Allogene Therapeutics, Inc. | 44,178 | 0.00 USD | |
| 07 Mar 2022 | GIFT | Kronos Bio, Inc. | 211,000 | 0.00 USD | |
| 07 Mar 2022 | GIFT | Kronos Bio, Inc. | 211,000 | 0.00 USD | |
| 07 Mar 2022 | OTHER | Allogene Therapeutics, Inc. | 412,618 | 0.00 USD | |
| 07 Mar 2022 | GIFT | Allogene Therapeutics, Inc. | 412,618 | 0.00 USD | |
| 12 Jan 2022 | PURCHASE | Allogene Therapeutics, Inc. | 15,000 | 12.60 USD | |
| 22 Jun 2021 | GRANT_AWARD | Kronos Bio, Inc. | 20,600 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Allogene Therapeutics, Inc. | 16,498 | 0.00 USD | |
| 11 Jun 2021 | GIFT | Allogene Therapeutics, Inc. | 500,000 | 0.00 USD | |
| 04 Jun 2021 | EXERCISE | Latch, Inc. | 30,000 | — | |
| 04 Jun 2021 | EXERCISE | Latch, Inc. | 30,000 | — | deriv |
| 12 Feb 2021 | PURCHASE | Tishman Speyer Innovation Corp. II | 25,000 | — |
4 purchases reported after at least 12 months of silence — most recent on 12 Feb 2021.